Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05640453 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 25, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: May 15, 2023 to May 15, 2026v3
  2. Trial status: Not Yet Recruiting to Recruiting Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to determine the effect of pregabalin versus dexmedetomidine on the treatment and lasting duration of delirium in fast tracking elderly patients after Coronary Artery Bypass Grafting.
Trial Details
NCT Number NCT05640453
Lead Sponsor Tanta University
Conditions Pregabalin, Delirium Treatment, Coronary Artery Bypass Grafting, Dexmedetomidine
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov